UNIGE document Scientific Article
previous document  unige:1856  next document
add to browser collection
Title

Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants

Authors
Buller, Harry R.
Halperin, J L.
Prins, M.
Published in Journal of Thrombosis and Haemostasis. 2008, vol. 6, no. 2, p. 227-9
Keywords Anticoagulants/standards/therapeutic useBias (Epidemiology)Case ManagementClinical Trials, Phase III as Topic/methods/standardsCost-Benefit AnalysisDouble-Blind MethodFibrinolytic Agents/standards/therapeutic useHeparin/therapeutic useHeparin, Low-Molecular-Weight/therapeutic useHumansPatient SelectionProfessional PracticeProthrombin Time/instrumentationQuality of LifeRandomized Controlled Trials as Topic/methods/standardsThrombophilia/drug therapyTreatment OutcomeVitamin K/antagonists & inhibitors
Identifiers
PMID: 18034770
Full text
Article (Accepted version) (72 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research groups Geneva Platelet Group (13)
La maladie thromboembolique veineuse (808)
Citation
(ISO format)
BULLER, Harry R. et al. Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants. In: Journal of Thrombosis and Haemostasis, 2008, vol. 6, n° 2, p. 227-9. doi: 10.1111/j.1538-7836.2007.02848.x https://archive-ouverte.unige.ch/unige:1856

352 hits

0 download

Update

Deposited on : 2009-06-02

Export document
Format :
Citation style :